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Nucleophosmin (NPM) is an important phosphoprotein with pleiotropic functions in various cellular processes. Although
phosphorylation has been postulated as an important functional determinant, possible regulatory roles of this modifi-
cation on NPM are not fully characterized. Here, we find that NPM is dephosphorylated on various threonine residues
(Thr199 and Thr234/237) in response to UV-induced DNA damage. Further experiments indicate that the serine/threonine
protein phosphatase PP1 is a physiological NPM phosphatase under both the genotoxic stress and growth conditions. As
a consequence, NPM in its hypophosphorylated state facilitates DNA repair. Finally, our results suggest that one possible
mechanism of this protective response lies in enhanced NPM-retinoblastoma tumor suppressor protein (pRB) interaction,
leading to the relief of the repressive pRB–E2F1 circuitry and the consequent transcriptional activation of E2F1 and several
downstream DNA repair genes. Thus, this study unveils a key phosphatase of NPM and highlights a novel mechanism
by which the PP1–NPM pathway contributes to cellular DNA damage response.
INTRODUCTION
Nucleophosmin (NPM) is an abundant and ubiquitously
expressed nucleolar phosphoprotein indispensable for vari-
ous cellular processes, such as ribosome biogenesis, cell
cycle progression, apoptosis, and cell differentiation (Lim
and Wang, 2006; Okuwaki, 2008). Its activities on these
processes might be closely relevant to its role in human
cancer, in which NPM is often found overexpressed or mu-
tated (Grisendi et al., 2006). However, the biological connec-
tion of NPM to tumorigenesis and the underlying molecular
mechanisms remain undetermined. One aspect of NPM-
associated cell growth control lies in the acute response of
mammalian cells to environmental stresses induced by
DNA-damaging agents (Gjerset, 2006). Previously, we and
others have demonstrated the significance of NPM in cellu-
lar DNA repair capacity, survival after DNA damage, and
the maintenance of genomic stability (Wu et al., 2002a,b;
Colombo et al., 2005; Li et al., 2006). Its role in this regard is
partly mediated by its contribution to the stabilization and
activation of the tumor suppressor p53 (Colombo et al., 2002;
Maiguel et al., 2004). Underlying molecular mechanisms
have not been characterized in detail.
Consistent with its pleiotropic functions in the cells, NPM
is tightly regulated through multiple mechanisms. Its ex-
pression and subnuclear localization alter under various
cellular contexts (Yung et al., 1985; Borer et al., 1989; Chan,
1992; Wu and Yung, 2002; Brady et al., 2004; Liu et al., 2007b).
NPM also has been shown to undergo various types of
posttranslational modification (Okuwaki, 2008). Several ki-
nases, including casein kinase 2, nuclear kinase II, Polo-like
kinase, ATR, and cyclin-dependent kinases (CDK1/cyclin B,
CDK2/cyclin E, and CDK2/cyclin A) have been known to
modify NPM, which is generally regarded as a phosphopro-
tein (Chan et al., 1990; Peter et al., 1990; Jiang et al., 2000;
Okuda et al., 2000; Tokuyama et al., 2001; Okuwaki et al.,
2002; Szebeni et al., 2003; Maiguel et al., 2004; Zhang et al.,
2004; Negi and Olson, 2006). Consequently, certain func-
tional attributes of NPM, such as RNA binding activity and
centrosome duplication regulation, are tightly coordinated
with its phosphorylation at various residues. Although these
signaling pathways have been well documented, knowledge
of NPM-targeting phosphatase, as well as the regulatory and
functional significance of NPM dephosphorylation, has re-
mained elusive.
In the present study, we discovered that NPM is targeted
by the protein phosphatase PP1. Depletion of PP1 by
RNA interference (RNAi) in cycling or irradiated cells re-
sulted in increased steady-state levels of phospho-NPM,
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indicating that PP1 is a physiological NPM phosphatase.
We further demonstrated that the PP1–NPM pathway is
activated by DNA damage signal. Crucially, dephosphory-
lation of NPM enhances its activity in facilitating DNA
repair. Finally, our results indicated that one possible mech-




Anti-NPM monoclonal antibody (mAb) was kindly provided by Dr. P. K.
Chan (Balyor College of Medicine, Houston, TX). Mouse monoclonal anti-
bodies against E2F1, -actin, retinoblastoma tumor suppressor protein (pRB),
and rabbit polyclonal antisera against PP1 and PP1 were obtained from
Santa Cruz Biotechnology (Santa Cruz, CA). Anti-PP1/ rabbit polyclonal
antibodies were purchased from Millipore (Billerica, MA). Rabbit antisera
against phospho-NPM (Thr199), phospho-NPM (Thr234/237), and phospho-
PP1 (Thr320) were from Cell Signaling Technology (Danvers, MA). All
chemicals were purchased from Sigma-Aldrich (St. Louis, MO), except where
otherwise indicated.
Cell Culture and Transfection
HeLa, 293T, and H1299 cells were grown as a monolayer in DMEM supple-
mented with 10% fetal bovine serum and 100 U/ml penicillin and strepto-
mycin, in a 5% CO2-humidified incubator at 37°C. Cells were transfected
using Lipofectamine (Invitrogen, Carlsbad, CA) according to the manufactur-
er’s instructions. Transient transfection was done for 24–54 h before cell
harvest, unless otherwise noted.
Reporter Gene Assay
For the E2F1 (Lin et al., 2006) and p53 (Chan et al., 2005) promoter reporter
assay, the cells extracts were obtained with 1 Reporter lysis buffer (Promega,
Madison, WI), and the reporter/luciferase activity was measured using Lu-
ciferase assay reagent (Promega) following the manufacturer’s recommenda-
tions. Luciferase activity was measured with Luminometer AutoLunmat
LB953 (Berthold, Norwalk, CT) and normalized to the corresponding -ga-
lactosidase activity.
UV and Phosphatase Inhibitor Treatments
Cells were grown to 80% confluence in 6-cm dishes. DNA damage was
achieved by exposing the cells to UV irradiation (50 J/m2). Cells were har-
vested at indicated times. In some experiments, they were treated with
okadaic acid (OA; 50 nM) or calyculin A (5 nM) for 3 h before UV treatment.
Western Blot Analysis
Cells were harvested and washed twice in phosphate-buffered saline (PBS)
and then lysed in ice-cold Gold lysis buffer (1% Triton X-100, 10% glycerol, 1
mM sodium orthovanadate, 1 mM EGTA, 10 mM NaF, 1 mM sodium pyro-
phosphate, 10 M -glycerophosphate, 20 mM Tris-HCl, 137 mM NaCl, 5 mM
EDTA, and cocktail protease inhibitor (Sigma-Aldrich), pH 7.9) for 30 min.
Lysates were boiled in 2 urea sample buffer dye (100 mM Tris-HCl, pH 6.8,
4% SDS, 0.2% bromphenol blue, 20% glycerol, 200 mM -mercaptoethanol,
and 8 M urea), and then fractionated by SDS-polyacrylamide gel electro-
phoresis (PAGE).
Western blot analysis was performed after electrophoretic separation of
polypeptides by 8 or 10% SDS-PAGE and transfer to Hybond-polyvinylidene
difluoride membrane (GE Healthcare, Piscataway, NJ). Blots were probed
with the indicated primary and appropriate secondary antibodies. Immuno-
bands were subsequently detected by the enhanced chemiluminescence reac-
tion (GE Healthcare).
Generation of Small Interfering RNAs (siRNAs)
To establish a plasmid-based double-stranded RNAi system targeting endog-
enous PP1, PP1, or PP1, annealed oligonucleotides corresponding to
partial sequence were designed and ligated to pSuper.neoGFP (Oligo-
engine, Seattle, WA) according to manufacturer’s instruction. The cDNA
sequence of the targeted mRNA region for different genes is as follows: PP1,
5-GAGACGCTACAACATCAAA-3; PP1, 5-GTTCGAGGCTTATGTATCA-
3; PP1-2, 5-TGTGCAGATGACTGAAGCA-3, PP1, 5-AGAGGCAGTTGGT-
CACTCT-3; E2F1, 5-CGCTATGAGACCTCACTGA-3; and E2F1-2, 5-GTG-
GACTCTTCGGAGAACT-3.
Site-directed Mutagenesis
To generate phosphorylation-site mutant constructs of NPM for expression in
the cells, an appropriate set of oligonucleotide primers were used for site-
directed amino acid substitutions (serine or threonine to alanine). We used
full-length NPM cDNA in plasmid pCR3.1-FLAG-NPM as a template, and the
primer sequences for cloning S125A, T199A, T199D, T234/237A, and T234/
237D variants were listed in Supplemental Table S1.
Immunoprecipitation
The cells were harvested, washed twice in ice-cold PBS, and the cell pellets
were resuspended in hypotonic RSB buffer (10 mM Tris-HCl, pH 7.4, 10 mM
NaCl, 3 mM MgCl2, and 1 mM phenylmethylsulfonyl fluoride) at 4°C for 10
min. An equal volume of an RSB  NP40 (20%) buffer was added next and
incubated at 4°C for 10 min. Nuclei were collected by centrifuged at 3000 rpm
at 4°C for 5 min and resuspended in ice-cold Gold lysis buffer (20 mM
Tris-HCl, pH 7.5, 10% glycerol, 1% Triton X-100, 1 mM sodium pyrophos-
phate, 100 mM -glycorophosphate, 1 mM sodium orthovanadate, 137 mM
sodium chloride, 5 mM EDTA, 1 mM EGTA, and protease inhibitor cocktail)
for 30 min and subsequently centrifuged at 12,000 rpm at 4°C for 30 min.
Equal amounts of nuclei extract protein (1 mg) were incubated with the
indicated antibodies (2 g) at 4°C for 2 h with rotation. The immunocom-
plexes were captured with protein G-Sepharose (30 l) for 2 h at 4°C with
rotation. The protein G–antigen–antibody complexes were washed four times
with the Gold lysis buffer and boiled in 2 urea sample buffer dye (100 mM
Tris-HCl, pH 6.8, 4% SDS, 0.2% bromphenol blue, 20% glycerol, 200 mM
-mercaptoethanol, and 8 M urea) for subsequent PAGE and immunoblotting
analysis as described above.
Chromatin Immunoprecipitation (ChIP)
ChIP experiments were done essentially as described previously (Liu et al.,
2007a). Cross-linked, sonicated chromatin was precleared before being incu-
bated with 2 g of mouse mAb (pRB or E2F1) and rotated at 4°C overnight.
Normal mouse immunoglobulin (Ig)G was used for the mock immunopre-
cipitation. After extensive washes, immunocomplexes were treated with pro-
teinase K and decross-linked. Bound DNA in the pRB ChIP was extracted,
purified, and subjected to polymerase chain reaction (PCR) analysis by using
primers corresponding to the E2F1 gene promoter sequence (Lin et al., 2006).
After 35 cycles of amplification, PCR products were run on a 2% agarose gel
and analyzed by ethidium bromide staining. For anti-E2F1 ChIP, bound DNA
was subjected to quantitative real-time PCR analysis.
RNA Isolation and Reverse Transcription (RT)-PCR
Total cellular RNAs were isolated from cells using the Trizol Reagent (In-
vitrogen) according to the manufacturer’s instructions. Total RNA (2–5 g)
was reverse transcribed with reverse transcriptase (Moloney murine leukemia
virus) (Invitrogen) at 37°C for 52 min. cDNA synthesis was primed with
random hexamer. The E2F1 and internal control -actin genes were amplified
with the following specific primers: E2F1, 5-CCGAGGTGCTGAAGGTG-
CAGA-3 (sense), 5-TCTTCCCAGGGCTGATCCCAC-3 (antisense); and -actin,
5-AGAAAATCTGGCACCACACC-3 (sense), 5-CCATCTCTTGCTCGAA-
GTCC-3 (antisense). The PCR products were resolved on 1.5% agarose gels
and stained with ethidium bromide.
Real-Time PCR
For quantitative determination by real-time PCR, target transcripts or ChIP
products were analyzed using the LightCycler system and Power SYBR Green
PCR Master Mix (Roche Diagnostics, Indianapolis, IN). Transcript levels were
normalized to glyceraldehyde-3-phosphate dehydrogenase (GAPDH) values
of the respective sample, and represent mean  SD of at least three indepen-
dent experiments. Sequences for the primers used in this experiment are as
follows: E2F1, 5-AGATGGTTATGGTGATCAAAGCC-3 (sense), 5-ATCT-
GAAAGTTCTCCGAAGAGTCC-3 (antisense); GAPDH, 5-GGTATCGTG-
GAAGGACTCATGAC-3 (sense), 5-ATGCCAGTGAGCTTCCCGT-3 (antisense);
XPC, 5-CATCATCCCAGCCCGCTTTAC-3 (sense), 5-CCACTTCACCAGGTT-
TGAGAGG-3 (antisense); DDB2, 5-GCACCTCACACCTATCAAG-3 (sense),
5-GAGCTGACACATCATCTTCC-3 (antisense); and RPA3, 5-CGTCACTA-
AGCAGCCAATC-3 (sense), 5-GCACCAATCAGCGAAGAC-3 (antisense).
For quantitative analysis of anti-E2F1 ChIP experiments, primers corresponding
to gene promoters were used: XPC, 5-GAAATAGAGAGAAACCTGTTGT-3
(sense), 5-CTAGTCACGCCCCTAAAG-3 (antisense); and DDB2, 5-ATGTTT-
GGCGGGAAGTTG-3 (sense), 5-TCTGGGGAGAAACAAGGC-3 (antisense).
The results are given as a percentage of input and represent mean  SD of at
least three independent experiments. Triplicate PCRs were performed for all
experiments.
In Vitro Phosphatase Assay
The cells were okadaic acid treated (50 nM) for 8 h before harvest. Nuclei
extracts were prepared and subjected to immunoprecipitation by using the
anti-NPM antibody. The immunocomplexes were washed with reaction
buffer (1 mM MnCl2 and 5 mM caffeine). One unit of PP1 (New England
Biolabs, Ipswich, MA) was added to the immunocomplexes for 1 h at 30°C.
For inhibition studies, the immunocomplexes and PP1 were incubated in the
presence of 1 M OA. Degree of dephosphorylation was analyzed by SDS-
PAGE and subsequently immunoblotting.
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Measurement of Thymine Dimers
To estimate the DNA repair capacity of cells, the amounts of thymine dimers
in UV-irradiated cells were measured by enzyme-linked immunosorbent
assays (ELISAs) as described previously (Zhai et al., 2005) using an anti-
thymine dimer antibody (Abcam, Cambridge, MA). DNA was extracted from
the cells at the indicated times postirradiation. For statistical significance of
quantitative comparisons, calculations were done by the SigmaPlot software
(Systat Software, San Jose, CA).
DNA Repair Capacity/Host Cell Reactivation (HCR)
Assay
This method for measuring nucleotide excision repair (NER) in response to
UV irradiation was performed based on a previous report (Athas et al., 1991).
The pCAT control vector (Promega) is a nonreplicated plasmid, under control
of simian virus 40 promoter and enhancer sequences. The plasmid was
treated with or without UV (254 nm) at the dose of 500 J/m2 and then
cotransfected with unirradiated pGL3luc (as an internal control) as well as
plasmids encoding various phosphorylation-site mutants of NPM into HeLa
cells. The cells were lysed in 1 Reporter lysis buffer 24 h after transfection,
and chloramphenicol acetyltransferase (CAT) activity was detected as de-
scribed previously (Wu et al., 2002a,b). After normalization, relative CAT
activity was expressed as the percent of activity in cells transfected with the
UV-irradiated plasmid over those harboring the undamaged plasmid. For
statistical significance of quantitative comparisons, calculations were done by
the SigmaPlot software.
RESULTS
NPM Is Subject to Dephosphorylation at Multiple Sites
To characterize the involvement of NPM in cellular response
to gentoxic stress, we first tested whether DNA damage
affects the phosphorylation of several sites on NPM. HeLa
cells were treated with UV radiation, and cell lysates col-
lected at different time points posttreatment were probed
with phosphospecific NPM antibodies. Interestingly, UV en-
hanced dephosphorylation of NPM at Threonine 199, 234,
and 237 residues (Figure 1A). Dephosphorylation was de-
tected at 6 h after UV treatment and sustained at 9 h. Similar
patterns of modification changes were also evident in the
293T and p53-null H1299 cell lines (Supplemental Figure S1).
It was reported previously that PP1 is a candidate phos-
phatase for nucleolar proteins such as nucleolin and NPM
(Kotani et al., 1998). In line with this observation, we found
that the phosphorylation levels of NPM on Thr199 and
Thr234/237 were significantly enhanced in cells treated with
PP1/PP2A phosphatase inhibitor OA or calyculin A (Sup-
plemental Figure S2, A and B), thus providing further sup-
port to the notion that phosphorylation of this protein is
counterbalanced by the action of phosphatase under normal
growth condition. Based on these results, we next sought to
determine whether PP1 is the specific phosphatase that is
responsible for UV-induced NPM dephosphorylation. To
this end, we first assessed the changes in the PP1 activity
upon irradiation by performing immunoblotting with an
antibody that specifically recognizes phospho-Thr320 of
PP1. This modification was shown previously to be linked to
the inactivation of PP1 enzymatic activity (Kwon et al., 1997;
Liu et al., 1999). As shown in Figure 1B, our results showed
that the level of phospho-Thr320 was reduced after UV
treatment, indicating an up-regulation of PP1 phosphatase
activity that is responsive to DNA damage. Next, to further
investigate whether PP1 can indeed dephosphorylate NPM,
we carried out an in vitro phosphatase assay. By monitoring
the phosphorylation of endogenous NPM immunoprecipi-
tated from cells, we found that purified recombinant PP1 is
capable of removing phosphate groups on the Thr199 and
Thr234/237 residues of NPM (Figure 1C and Supplemental
Figure S2C). Furthermore, such specific phosphatase activity
was lost upon inhibitor treatment (Supplemental Figure
S2C). Together, these results showed that UV treatment is
capable of inducing dephosphorylation of NPM at several
sites and that PP1 is likely to be involved in this removal of
phosphorylation after DNA damage.
Identification of Specific Isoform of PP1 That Targets
NPM after DNA Damage
We next aimed to pinpoint the specific isoform of PP1 re-
sponsible for mediating UV-induced dephosphorylation of
NPM. Because the mammalian genomes encode three
closely related PP1 genes—, , and —specific ablation of
individual PP1 isoform expression was achieved by express-
ing isoform-specific short hairpin RNA(shRNA) (Figure 2A).
HeLa cells depleted of either PP1 isoform as well as control
were UV irradiated (Supplemental Figure S3A), and the
level of phosphorylation of NPM on Thr199 or Thr234/237
was measured at 0, 3, and 6 h after treatment. Among the
three isoforms, depletion of PP1 caused dramatic NPM
hyperphosphorylation, whereas PP1 and - knockdown
had little effect on the basal phosphorylation level (Figure 2B
and its shorter exposed version in Supplemental Figure
S3B). Furthermore, knockdown of PP1, but not of PP1 or
PP1, blocked the UV-induced dephosphorylation of NPM
on Thr199 and Thr234/237 (Figure 2B and Supplemental
Figure S3B). Similar outcomes of PP1 knockdown also
were observed in 293T cells (Supplemental Figure S3C).
Consistently, when PP1 was overexpressed in cells, phos-
phorylation at these threonine residues underwent consid-
erable reduction (Supplemental Figure S3D). An association
of transiently overexpressed (Figure 2C) or endogenous
(Figure 2D) PP1 with NPM also was found in coimmuno-
precipitation experiments. Specificity of such interaction
was reinforced by the observations that PP1 and PP1 did
not coprecipitate NPM (Figure 2C). Collectively, these re-
sults strongly indicate that PP1 plays an important role in
Figure 1. NPM undergoes dephosphorylation at multiple sites in
response to UV-induced DNA damage. (A) HeLa cells were ex-
posed to 50 J/m2 UV irradiation. Lysates were prepared from cells
collected at the indicated times postirradiation. Western blotting
was performed using the indicated antibodies. (B) Unirradiated and
irradiated HeLa cells were harvested at the indicated times after UV
(50 J/m2) treatment. Equal amounts of lysate proteins were sepa-
rated by PAGE and subjected to immunoblotting with antibodies
for phospho-PP1 (Thr320), PP1, and -actin. (C) Lysates were
prepared from HeLa cells (previously treated with 50 nM okadaic
acid; Input) and subjected to immunoprecipitation using anti-NPM
antibody. In vitro solid phase phosphatase assay was performed on
the immunoprecipitates as described in Materials and Methods (with
recombinant phosphatase, rPP1). The resultant products were
probed with the indicated antibodies. HC, heavy chain.
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dephosphorylating NPM on Thr199 and Thr234/237 upon
UV irradiation.
We also characterized the dephosphorylation of NPM in a
more comprehensive manner, by conducting a mass spec-
trometry-based comparative phosphoproteome analysis on
NPM isolated from control and PP1 knockdown cells (see
Supplemental Material for detailed methods). Based on
phosphopeptide profiling, we identified three additional
phosphorylation sites on NPM (Ser4, Ser70, and Ser125;
Supplemental Table S2 and Supplemental Figure S3E). How-
ever, quantitative comparison of phosphopeptides harbor-
ing Ser4 and Ser70 did not indicate significant changes in
their abundance between the control and knockdown sam-
ples but revealed a slightly lower level of peptides with
Ser125 phosphorylation in the PP1-depleted cells (Supple-
mental Table S2 and Supplemental Figure S3E). We thus
concluded that the phosphorylation levels of these residues
are not subject to PP1-mediated dephosphorylation.
Phosphorylation of NPM Impairs Cellular Response to
DNA Damage by UV
We demonstrated previously an ability of NPM in endowing
the cells with a greater NER activity under UV damage (Wu
et al., 2002a,b). It is therefore possible that the observed
UV-induced dephosphorylation of NPM may be a determi-
nant for this protective function of NPM. To address this
issue, we next undertook a reporter plasmid-based assay to
assess the effect of NPM phosphorylation on cellular DNA
repair capacity. Consistent with the previous studies, over-
expression of wild-type NPM rescued the expression of
reporter from UV-damaged plasmid, indicating an increased
host NER activity (Figure 3A). Interestingly, expression of a
variant of NPM in which Thr199/234/237 were changed to
Ala (3A) led to an even further elevated reporter activity,
whereas the stimulatory effect was abolished in the T199/
234/237D (3D) mutant.
To further examine the role of NPM dephosphorylation in
cellular response to UV damage in vivo, we measured by
ELISA the cellular capacity of removing UV-induced thy-
mine dimers. HeLa cells were transiently transfected with
various phosphorylation-site mutants of NPM and subse-
Figure 2. PP1 is the physiological NPM phosphatase in response
to UV. (A) Ablation of endogenous expression of the three PP1
isoforms was achieved by RNAi. HeLa cells transiently harboring
control-, PP1-, PP1-, or PP1-targeting shRNA (54 h) were har-
vested. Equal loadings of whole-cell extracts were immunoblotted
with antibodies against specific PP1 isoforms, and -actin. (B) HeLa
cells transiently harboring control-, PP1-, PP1-, or PP1-targeting
shRNA (54 h) were exposed to UV irradiation (50 J/m2). Equal
loadings of whole-cell extracts derived at 0, 3, and 6 h posttreatment
were immunoblotted with the indicated antibodies. (C and D) Co-
precipitation of NPM with PP1. HeLa cells were transfected with
constructs encoding enhanced green fluorescent protein (EGFP) or
EGFP-tagged PP1 (left), PP1 (middle), or PP1 (right) (C). Immu-
noprecipitation (IP) of the cell lysates was done using EGFP
antibodies and subsequently analyzed by immunoblotting with
antibodies against corresponding PP1 isoforms (PP1x, top) and
NPM (bottom). (D) Anti-NPM immunoprecipitates (IP) from
HeLa cell extracts (Input) were probed with antibodies against
NPM (top) and PP1 (bottom).
Figure 3. NPM phosphorylation status modulates cellular re-
sponse to UV-induced DNA damage. (A) Assay for DNA repair
capacity was performed as described in Materials and Methods. HeLa
cells were transfected with control vector () or the indicated
FLAG-tagged NPM (FLAG-NPM) constructs (3A and 3D represent
site-directed mutants in which the Thr199, Thr234, and Thr237
residues were respectively altered to alanine and aspartic acid),
along with a CAT reporter plasmid damaged with UV. Same ex-
periments were done with an unirradiated CAT plasmid. DNA
repair capacity was measured based on the normalized CAT activity
and was expressed as percentage of activity in cells transfected with
the UV-irradiated plasmid over those with unirradiated plasmid.
*p  0.05; **p  0.01. (B) Phosphorylation-defective mutant of NPM
enhances the capacity of cells to remove thymine dimers. Cells were
transfected with the indicated constructs as described in A. These
cells were subsequently irradiated with UV and lysed immediately
(at time 0) or at the times indicated. The thymine dimers were
analyzed by ELISA (see Materials and Methods) and presented as the
percentage to those at time 0. Data presented are means  SD of
four independent experiments. *p  0.05, the wild-type (wt) cells
versus the vector; **p  0.01, the 3A cells versus the 3D cells. (C)
Protein expression of the overexpressed constructs in B (at time 0 of
UV treatment) was monitored by Western blotting analysis, by
using anti-FLAG and anti--actin antibodies.
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quently irradiated (Figure 3C). In cells that expressed con-
trol vector and the phosphomimetic mutant (3D) of NPM,
30% of thymine dimers detected immediately after UV
irradiation (at time 0) were removed within 3 h after irradi-
ation, and the remaining damage was slightly decreased up
to 9 h (Figure 3B). In contrast, phosphorylation-defective
version of NPM (3A) substantially enhanced the ability of
the cells to repair thymine dimers, especially within the first
6 h of UV treatment. Together, these data clearly show that
the dephosphorylated species of NPM promotes repair of
DNA damage induced by UV.
PP1-mediated Dephosphorylation of NPM Promotes
E2F1 Expression
Next, we sought to further delineate the mechanism under-
lying NPM’s involvement in DNA repair. Recent evidence
has supported a role of NPM in the transcriptional regula-
tion of E2F1 (Lin et al., 2006; Liu et al., 2007b). Coincidentally,
E2F1 protein was reported to undergo accumulation after
DNA damage (Lin et al., 2001; Ianari et al., 2004). As we
uncovered the UV-induced NPM dephosphorylation, we
also discovered a concomitant rise in E2F1 mRNA and pro-
tein levels in response to DNA damage (Supplemental Fig-
ure S4, A and B). Berton et al. (2005) further demonstrated in
an in vivo context that such up-regulation promotes DNA
repair. Based on these observations, we therefore set out to
examine whether the role of dephosphorylated NPM in
DNA repair is linked to E2F1 regulation.
First, quantitative RT-PCR was carried out to examine the
expression profile of E2F1 gene in cells that harbor the
wild-type, 3A, or 3D variant of NPM (Figure 4A). As shown
previously (Lin et al., 2006), overexpression of the wild-type
construct led to an increase in the E2F1 transcript level
compared with the control. Interestingly, the hypophos-
phorylated form of NPM (3A) augmented this expression
even further. Consistently, this NPM mutant could highly
activate the E2F1 promoter activity, as shown by a reporter
assay (Figure 4B). In contrast, expression of the phosphomi-
metic variant (3D) did not result in any significant alteration
of the E2F1 mRNA level (Figure 4A). Another phosphode-
fective mutant that was altered on one of the MS-identified
phosphorylation sites (S125A) also did not further activate
E2F1 promoter activity compared with wild-type NPM
(Supplemental Figure S4C), suggesting a lack of involve-
ment of this residue in this functional aspect.
Our above-mentioned finding of PP1’s role in NPM de-
phosphorylation (Figure 2) also suggests its potential in-
volvement in modulating E2F1 expression under DNA dam-
age condition. To resolve this issue, we next assessed the
effect of PP1 knockdown in a promoter reporter assay.
Indeed, we found that reduction of PP1 by shRNA but not
that of PP1 or PP1, abolished the UV-induced activation
of E2F1 promoter (Figure 4C and Supplemental Figure S4D).
Moreover, the increase in E2F1 protein levels in response to
UV irradiation was lost upon depletion of PP1 (Figure 2B).
In line with these observations, inactivation of phosphatase
activity by calyculin A treatment also down-regulated the
UV-induced E2F1 protein expression (Supplemental Figure
S4E). Collectively, our data imply that the UV-responsive
transcriptional activation of E2F1 may be mediated through
the action of PP1 on NPM.
Dephosphorylated NPM Alleviates pRB-mediated
Transcriptional Repression of E2F1
pRB is known to, via complex formation with E2F1, coun-
terbalance the activation potential of E2F1 at the transcrip-
tional level, and its occupancy of the E2F1 gene promoter
has been linked to its gene regulation (Polager and Ginsberg,
2008). Recent studies have pointed to an involvement of
NPM in the regulation of such transcriptional network (Lin
et al., 2006; Liu et al., 2007b). Therefore, to elucidate how
dephosphorylated NPM could activate E2F1 gene expres-
sion, we next assessed the binding of pRB to the E2F1
promoter in the context of DNA damage by using ChIP.
After UV irradiation, we found a loss of pRB binding to the
E2F1 binding site within the E2F1 gene promoter (Figure
5Aa, lanes 1 and 2). Interestingly, compared with the wild-
type protein, expression of the nonphosphorylatable variant
of NPM (3A) also led to a decrease of pRB promoter binding
(Figure 5Ab, lanes 3 and 4). On the contrary, knockdown of
PP1 expression augmented promoter recruitment (Figure
5Ac, lanes 5 and 6). Collectively, these findings are in close
agreement with the above observations that linked PP1-
mediated dephosphorylation of NPM to E2F1 gene activa-
tion (Figure 4).
Consistent with an activation of E2F1, there was a disrup-
tion of the E2F1–pRB complex after UV treatment (Figure
5B). Intriguingly, coimmunoprecipitation experiments also
showed that there was a coprecipitation of pRB with NPM
upon UV irradiation, which was not detectable under mock
treatment (Figure 5C and Supplemental Figure S5). Such
association of NPM with pRB was further evident when
Thr199/234/237 were substituted with Ala, compared with
wild-type and the 3D mutant of NPM (Figure 5D), strongly
suggesting that the NPM–pRB interaction depends on de-
phosphorylation of these residues. Consistently, upon
siRNA-mediated reduction of intracellular PP1, which was
Figure 4. PP1-mediated NPM hypophosphorylation triggers
E2F1 expression. (A) Total RNA was extracted from HeLa cells
ectopically expressing empty vector (), wild-type (wt), T199/234/
237A (3A), or T199/234/237D (3D) variant of NPM. The mRNA
level of E2F1 gene in these cells was measured by quantitative
RT-PCR (see Materials and Methods). Western blotting results shown
on the bottom illustrate the expression levels of the indicated con-
structs. (B) Promoter reporter assay was performed on HeLa cells
cotransfected with E2F1-Luc reporter gene and the indicated variant
of NPM. Bars are means of triplicates  SDs. Expression levels of
the indicated constructs were monitored by anti-FLAG and anti--
actin immunoblotting analysis, as shown on the bottom. (C) HeLa
cells transiently harboring control-, PP1-, PP1-, or PP1-targeting
shRNA (54 h) were exposed to UV irradiation (50 J/m2). Cells were
lysed at 6 h postirradiation and subjected to reporter gene assay as
described in B. NS, p  0.05; **p  0.01.
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shown to increase the phosphorylation of NPM (Figure 2B),
a loss of interaction between NPM and pRB was observed
(Figure 5E). Conversely, lack of PP1 led to an up-regulated
complex formation between E2F1 and pRB (Figure 5F). To-
gether, these results demonstrate that the interaction of pRB
with hypophosphorylated NPM, in response to UV damage
and mediated by PP1, relieves its transcriptional repression
activity on E2F1.
Dephosphorylated NPM Promotes DNA Damage Repair
through an E2F1-dependent Mechanism
Finally, to clarify whether E2F1 underlies the protective
effect of NPM dephosphorylation in DNA damage response,
we again performed the in vivo DNA repair assay in the
context of E2F1 knockdown. Compared with control, cells
lacking E2F1 exhibited diminished ability to repair UV-
induced DNA damage (Figure 6A and Supplemental Figure
S6). Moreover, although overexpression of NPM-3A en-
hanced the DNA repair activity under UV treatment, down-
regulation of E2F1 expression effectively abolished such
augmentation of DNA repair. Consistent with a repressive
role on E2F1, overexpression of pRB also decreased the
cellular capacity of removing thymine dimers (Figure 6B),
mimicking the effect of E2F1 knockdown as well as the
phospho-mimetic mutant 3D (Figure 3B). Furthermore,
when expressed along with the NPM-3A mutant, pRB an-
tagonized the repair-promoting activity of the hypophos-
phorylated NPM. Collectively, these results demonstrate the
connection between NPM-mediated regulation of pRB-E2F1
pathway and the consequent activation of DNA repair.
To provide further mechanistic basis for the promotion of
DNA repair in the context of NPM-mediated E2F1 up-reg-
ulation, we next evaluated possible expression of E2F1 tar-
get genes that encode DNA repair proteins. To this end,
quantitative RT-PCR experiments demonstrated that the de-
phosphorylated form of NPM promotes the expression of
several NER genes, such as RPA3, XPC, and DDB2, that
were previously linked to E2F1 (Polager et al., 2002; Nichols
et al., 2003; Prost et al., 2007; Lin et al., 2009; Figure 6C).
Concomitantly, there was an increase in E2F1 occupancy of
the XPC and DDB2 promoters in the presence of NPM-3A
(Figure 6D), in line with the notion that these genes are
regulated by E2F1 in a UV-dependent manner (Prost et al.,
2007; Lin et al., 2009). Conversely, no significant changes in
these E2F-dependent attributes were evident in the context
of NPM–3D overexpression. Finally, we performed addi-
tional experiments (Supplemental Figure S7) to determine
whether dephosphorylated NPM also could functionally in-
teract with p53, another critical regulator of DNA damage
response. As shown by the reporter assay, whereas UV
treatment caused a dramatic up-regulation of p53 activity,
overexpression of wild-type NPM exerted a negative regu-
lation, consistent with previous observations (Maiguel et al.,
2004). However, overexpression of NPM-3A, compared with
the wild-type form, did not lead to discernible alteration in
the p53 transactivation activity (Supplemental Figure S7A).
Results of the flow cytometry-based cell cycle profiling also
revealed that overexpression of NPM-3A failed to affect the
progression of cell cycle and extent of apoptosis (Supple-
mental Figure S7B). These data therefore suggest that up-
regulation of E2F1 and its downstream DNA repair genes
may be a major mechanism through which dephosphory-
lated NPM favors repair of UV-induced DNA damage. Con-
sidered together, our findings provide strong evidence that,
rather than acting as a repair protein per se, NPM serves as
an integral component of the DNA damage response path-
way that regulates expression of DNA repair genes.
Figure 5. Dephosphorylated NPM prefers to associate with pRB
and disrupts the pRB-E2F1 interaction. (A) ChIP was performed as
described in Materials and Methods. Chromatin fragments were pre-
pared from HeLa cells subjected to the following treatments: (a)
mock (lane 1) or UV irradiation (50 J/m2, lane 2); (b) ectopic expres-
sion of wild type (lane 3) or the 3A mutant (lane 4) of NPM; or (c)
expression of control (lane 5) or PP1-targeting (lane 6) shRNA.
Immunoprecipitation was done with either control antibody (im-
munoglobulin G [IgG], bottom) or an antibody against pRB (-pRB,
middle). Products (200 base pairs) from final PCR analysis by
using primers specific to E2F1 promoter region were resolved by
1.5% agarose gel. DNA input (1/50 of immunoprecipitation) is
shown in the top panels. (B) Cells were treated with mock or UV
irradiation (50 J/m2). At 4 h posttreatment, cell lysates (panels on
the right) were prepared and immunoprecipitated with control
(IgG) and anti-E2F1 antibody. Immunoprecipitates and lysate input
(Input, 1/60 of IP, right) were probed for the specified proteins. (C)
Immunoprecipitation was done as described in B, except with the
use of control (IgG), -NPM, and -pRB antibody. (D) HeLa ells
were transfected with empty vector (vector), FLAG-tagged wild-
type NPM (NPM-wt), or phosphorylation site mutants T199/234/
237A (NPM-3A) and T199/234/237D (NPM-3D) for 24 h. Lysates
(60 input) were immunoprecipitated with anti-FLAG antibody
(IP) and subsequently immunoblotted using anti-pRB (top) and
anti-FLAG (bottom) antibodies, as indicated. Lysate input (Input) is
shown on the bottom. (E and F) Extracts were prepared from HeLa
cells ectopically expressing control or PP1-specific shRNA and
subsequently subjected to immunoprecipitation using anti-NPM (E)
or anti-E2F1 (F) antibody. Control antibody (IgG) was used for
mock immunoprecipitation. Immunocomplexes were probed with
specified antibodies. Immunoblotting of the input proteins (1/50 of
IP) is shown on the right of E. *, heavy chain of immunoglobulin G.
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DISCUSSION
Here, we report a new pathway through which PP1 signals
to NPM in response to DNA damage and consequently
promotes cellular DNA repair. DNA damage induces de-
phosphorylation of NPM at multiple sites, leading to en-
hancement of complex formation between NPM and pRB
and the subsequent upregulation of E2F1. Consequently,
such signaling pathway potentiates the cellular DNA repair
capacity.
As a multifunctional protein, dephosphorylated NPM
may exert its functions in DNA damage signaling through
modulating other critical regulators of cell growth and stress
in addition to E2F1. For example, disruption of the NPM–
ARF complex is known to contribute to p53-dependent ap-
optosis in the context of UV-induced DNA damage (Lee et
al., 2005; Gjerset, 2006). However, our attempt to character-
ize the role of NPM dephosphorylation in this functional
aspect did not reveal any effect of NPM–3A overexpression
on the p53 transactivation activity (Supplemental Figure
S7A) or on the cell cycle profile and extent of apoptosis
(Supplemental Figure S7B), further implying that the PP1–
NPM pathway may be functionally independent from the
ARF–NPM interaction and the p53-associated network. Fur-
thermore, the above-mentioned findings also potentially ex-
cluded the possibility that pRB-specific functions, such as
regulation of Skp2 and expression of apoptotic genes
(Young and Longmore, 2004; Assoian and Yung, 2008), are
altered by NPM binding in this stress condition. Finally,
although our previous report implicated nuclear factor
(NF)-B in the negative regulation of E2F1 during quies-
cence (Lin et al., 2006), we did not detect association of
NF-B with the E2F1 promoter under normal growth or
DNA damage condition (data not shown). Together, our
findings strongly suggest that derepression of the pRB–E2F1
circuitry is a predominant functional consequence of the
PP1-mediated NPM dephosphorylation during UV-in-
duced DNA damage repair.
Although it is widely assumed that phosphorylation of
NPM is intimately linked to its cellular roles in various
processes, we demonstrated that its dephosphorylation also
represents an activating event. Compared with the extensive
knowledge of the NPM phosphorylation and the kinases
involved, much less is understood about NPM dephosphor-
ylation and the enzymes that target this process. Our present
work attributed this phosphatase activity to PP1, which is
responsible for mediating the dephosphorylation of at least
three residues: Thr199, Thr234, and Thr237. Interestingly,
PP1 was shown previously to be predominantly in the
nucleolus and exhibit phosphatase activity toward nucleolar
phosphoproteins such as NPM (Kotani et al., 1998). Such
subcellular localization and putative substrate preference,
together with our findings, are consistent with the notion
that it is an authentic NPM phosphatase. Although our
current results excluded the other two PP1 isoforms ( and
), it is a formal possibility that other types of protein
phosphatase also may target NPM, either at overlapping or
distinct sites. Identity of such enzyme, as well as the func-
tional context under which it dephosphorylates NPM, re-
main to be investigated. Dissecting such signaling pathways
can provide further insight into how the multifunctional
NPM is regulated.
Although kinases play important roles in every signaling
pathway, removal of phospho-moiety from proteins by
phosphatases represents another key determinant in the
functional outcome of the signal transmission. In recent
years, it has become increasingly clear that phosphatases,
particularly those with serine/threonine specificity, are in-
timately involved in the cellular response to genotoxic
stress. Among the numerous members of this phosphatase
family, PP2A and PP5 were implicated previously in regu-
lating ATM autophosphorylation after DNA damage (Ali et
al., 2004; Goodarzi et al., 2004; Zhang et al., 2005). A recent
Figure 6. Protective role of dephosphorylated NPM in DNA dam-
age response is mediated through E2F1 and downstream NER
genes. (A) HeLa cells were transfected with control vector or the
FLAG-tagged NPM-3A construct, in combination with plasmids
encoding control or E2F1-targeting shRNA. Capacity of these cells
to remove thymine dimers upon UV treatment was measured as in
Figure 3B. The levels of thymine dimers were presented as the
percentage to those at time 0. Data presented are means  SD of
four independent experiments. *p  0.05, the vector cells versus the
vector/siE2F1 cells; **p  0.01, the 3A cells versus the 3A/siE2F1
cells. Western blotting results shown on the bottom illustrate the
expression levels of E2F1 in the indicated transfectants (-actin as a
control). (B) HeLa cells were transfected with control vector or the
FLAG-tagged NPM-3A construct, in combination with control or
plasmids encoding pRB. DNA repair assay was done as described in
A. Normalized data, at 10 h post-UV treatment, from the indicated
groups were plotted in the bar graph. TD, thymine dimers. *p 
0.05. (C and D) HeLa cells were transiently transfected with empty
vector (), T199/234/237A (3A), or T199/234/237D (3D) variant of
NPM and subsequently subjected to gene expression (C) and ChIP
(D) analyses. (C) Total RNA was extracted from these cells. The
relative mRNA level of E2F1 downstream genes XPC, DDB2, and
RPA3 was measured by quantitative RT-PCR (see Materials and Meth-
ods). (D) ChIP was performed as described in Materials and Methods.
Immunoprecipitation was done with either control antibody or an
antibody against E2F1. Bound DNA was subjected to quantitative
real-time PCR analysis to monitor E2F1 binding to the XPC and
DDB2 promoters. Relative promoter binding, expressed as normal-
ized ratio of IP to input, is shown (the values of the empty vector
group are represented as 1).
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report also pinpointed PP4 in the recovery from DNA dam-
age checkpoint by acting as a H2AX phosphatase (Nakada
et al., 2008). Interestingly, PP1 is activated in an ataxia tel-
angiectasia mutated-dependent manner after ionizing irra-
diation-induced DNA damage (Guo et al., 2002). This is in
line with our observations of the DNA damage-induced
activation of the PP1–NPM pathway. Despite these puta-
tive roles, more detailed investigations, particularly on iden-
tifying cellular substrates, are necessary to fully delineate
the functional link of these phosphatases to DNA damage
response.
Hyperphosphorylation of the pRB protein has been
known as an inactivating signal that promotes dissociation
of the pRB–E2F1 complex and reversion of pRB-mediated
transcriptional repression. Evidence from recent studies
supports a role of NPM in mediating the transcriptional
regulation of E2F1 (Lin et al., 2006; Liu et al., 2007b). Our
present work presents another mechanism for the negative
regulation of pRB: the dephosphorylated form of NPM pref-
erentially associates with pRB and sufficiently induces the
coincident dissociation of pRB from the E2F1 promoter re-
gion (Figure 5). This sequestration may be mediated by a
direct interaction between these two proteins, which was
demonstrated previously (Takemura et al., 1999; Liu et al.,
2007b). In addition, change in the subcellular localization
also may alter the functional attributes of pRB after DNA
damage. In support of this notion, recent reports have illus-
trated that NPM triggers a nucleolar migration of pRB after
DNA replication is completed (Takemura et al., 2002) and
that nucleolar residence of pRB critically depends on the
sumoylation of NPM (Liu et al., 2007b). It is therefore a
formal possibility that dephosphorylation of NPM contrib-
utes to or effects a spatiotemporal modulation of pRB in
response to DNA damage that ultimately leads to E2F1
up-regulation.
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